ArticleEMBO molecular medicine2019
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Liping Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this papercites it
ArticleEMBO molecular medicine2019
Liping Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.